JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4548 α-Amanitin

15 Citation

Summary: RNA polymerase II inhibitor

≥1 mg/mL
A4601 Empagliflozin (BI 10773)

5 Citation

Summary: SGLT-2 inhibitor for oral treatment of type 2 diabetes

insoluble in H2O; ≥20.75 mg/mL
A8254 SB 203580

45 Citation

Target: p38|PKB

Summary: P38 MAP kinase inhibitor

insoluble in H2O; ≥18.872 mg/mL
A4605 KU 55933

7 Citation

Summary: ATM inhibitor,potent and selective

≥41.67 mg/mL
A1832 Doxorubicin (Adriamycin) HCl

13 Citation

Target: Topoisomerases

Summary: A cytotoxic anthracycline antibiotic used in anticancer chemotherapy.

≥29 mg/mL
A1402 Gemcitabine HCl

4 Citation

Summary: Inhibits DNA synthesis,deoxycytidine analog

≥10.1 mg/mL
A2149 Bosutinib (SKI-606)

1 Citation

Target: Bcr-Abl|Src

Summary: Potent Abl/Src kinases

≥26.5 mg/mL
A2067 PI-103

1 Citation

Summary: Class I PI3K, mTOR and DNA-PK inhibitor

≥21.9 mg/mL
A2960 Loratadine

Target: Histamine H1 Receptors

Summary: Peripheral HH1R antagonist

insoluble in H2O; ≥19.14 mg/mL
A2307 PHA-665752

1 Citation

Target: c-MET

Summary: C-Met inhibitor,potent and ATP-competitive